Status:
RECRUITING
Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
Lead Sponsor:
Yunnan Cancer Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the value of rapid on-site evaluation（ROSE） in lymph node biopsy of breast cancer. The main question it aims to answer is:The ROSE technique was applied ...
Eligibility Criteria
Inclusion
- Patients had pathologically confirmed primary breast cancer
- Surgical treatment was available
Exclusion
- Previous history of surgery on the affected axilla, internal breast or chest
- Pregnant or breastfeeding patients
- Previous radiotherapy or chemotherapy
- Complicated history of other tumors
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06495736
Start Date
February 1 2024
End Date
February 1 2026
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yunnan Cancer Hospital
Kunming, Yunnan, China